Transarterial chemoembolization (TACE) is a minimally invasive procedure used primarily to treat liver cancer, also known as hepatocellular carcinoma (HCC). It involves the delivery of chemotherapy drugs directly into the blood vessels feeding a cancerous tumor, followed by the injection of embolizing agents to block these vessels. This dual approach aims to both deliver high concentrations of chemotherapy to the tumor and restrict its blood supply, causing the cancer cells to die.
